United States· US:60492-0075_2e94a3f2-2cd8-40bb-ae96-80dd2928c797
BAT
A medicinal product containing equine botulinum neurotoxin a immune fab2; equine botulinum neurotoxin b immune fab2; equine botulinum neurotoxin c immune fab2; equine botulinum neurotoxin d immune fab2; equine botulinum neurotoxin e immune fab2; equine botulinum neurotoxin f immune fab2; equine botulinum neurotoxin g immune fab2, registered in United States by Emergent BioSolutions Canada Inc.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- EQUINE BOTULINUM NEUROTOXIN A IMMUNE FAB2; EQUINE BOTULINUM NEUROTOXIN B IMMUNE FAB2; EQUINE BOTULINUM NEUROTOXIN C IMMUNE FAB2; EQUINE BOTULINUM NEUROTOXIN D IMMUNE FAB2; EQUINE BOTULINUM NEUROTOXIN E IMMUNE FAB2; EQUINE BOTULINUM NEUROTOXIN F IMMUNE FAB2; EQUINE BOTULINUM NEUROTOXIN G IMMUNE FAB2
- Manufacturer
- Emergent BioSolutions Canada Inc
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- July 5, 2026
Packs & prices · 4
- ndc1160492-0075-2
- ndc1160492-0075-4
- ndc1160492007526 VIAL, GLASS in 1 CARTON (60492-0075-2) / 50 mL in 1 VIAL, GLASS (60492-0075-1)
- ndc1160492007541 VIAL, GLASS in 1 CARTON (60492-0075-4) / 50 mL in 1 VIAL, GLASS (60492-0075-1)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d46fecf2-3278-4278-929e-a3c2cdf5caff GET /v1/drugs/d46fecf2-3278-4278-929e-a3c2cdf5caff?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAVENOUS",
"source": "ndc",
"strength": "4500; 3300; 3000; 600; 5100; 3000; 600",
"substance": "EQUINE BOTULINUM NEUROTOXIN A IMMUNE FAB2; EQUINE BOTULINUM NEUROTOXIN B IMMUNE FAB2; EQUINE BOTULINUM NEUROTOXIN C IMMUNE FAB2; EQUINE BOTULINUM NEUROTOXIN D IMMUNE FAB2; EQUINE BOTULINUM NEUROTOXIN E IMMUNE FAB2; EQUINE BOTULINUM NEUROTOXIN F IMMUNE FAB2; EQUINE BOTULINUM NEUROTOXIN G IMMUNE FAB2",
"productndc": "60492-0075",
"dosage_form": "LIQUID",
"dea_schedule": null,
"strength_unit": "[iU]/10mL; [iU]/10mL; [iU]/10mL; [iU]/10mL; [iU]/10mL; [iU]/10mL; [iU]/10mL",
"application_number": "BLA125462",
"marketing_category": "BLA"
}See everything about equine botulinum neurotoxin a immune fab2; equine botulinum neurotoxin b immune fab2; equine botulinum neurotoxin c immune fab2; equine botulinum neurotoxin d immune fab2; equine botulinum neurotoxin e immune fab2; equine botulinum neurotoxin f immune fab2; equine botulinum neurotoxin g immune fab2.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.